The Autoimmune Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
Autoimmune disorders have been one of the most prominent growth segments in the pharma industry over the last decade. A growing patient population and high levels of unmet need are the main drivers of market growth, and novel biologics are increasingly helping to fulfill patient need, with their high cost helping to drive market sales.
Study findings have also shown that the early use of anti-TNF drugs can help to halt/reverse disease progression. This has further expanded patient populations and prompted the use of these drugs in early-stage treatment.
The Autoimmune Market Outlook to 2013 provides comprehensive coverage of major markets within the global autoimmune area, incorporating a detailed epidemiological analysis of key indications and the main factors impacting their prevalence. Current leading brands of treatment within each indication are analysed and eight of the markets leading players are profiled.
With coverage of over 95% of the total market for autoimmune products, this report reviews the factors and underlying trends that are shaping the market and identifies the most promising areas of potential growth. Forecasts for currently marketed and key pipeline products over the 2009-13 period are also provided.
Table of Contents
Download Table of Contents as a PDF
Other users found this report page using the following search terms: autoimmune rheumatoid arthritis diabetes psoriasis multiple sclerosis IBD market landscape pdf autoimmune outlook competitive analysis 2013 pipeline clinical
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.
Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.